a month ago
MRK
AnalystsTerence FlynnTerence Flynn's Stock Forecasts
AnalystsTerence Flynn
Sectors:
Analyst Ranking
Top 5%
#276 out of 5520 analysts
Average Return
+17.03%
Win Rate
65%96 out of 148
Risk vs Reward
Poor
Good
Terence Flynn's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alumis IncALMS | +432.84% | $4.75 | $25.31 | 2025-08-15 - 2026-08-14 | Strong Buy |
Arcus Biosciences IncRCUS | +157.85% | $8.28 | $21.35 | 2025-05-09 - 2026-01-08 | Strong Buy |
Translate Bio IncTBIO1 | +147.91% | $15.07 | $37.36 | 2020-10-05 - 2021-09-14 | Strong Buy |
Blueprint Medicines CorpBPMC | +140.20% | $41.34 | $99.30 | 2017-03-13 - 2018-03-13 | Strong Buy |
Eli Lilly & CoLLY | +139.90% | $314.17 | $753.68 | 2023-03-01 - 2024-02-29 | Strong Buy |
Terence Flynn Analyst Color
Get additional color on Terence Flynn's coverage of popular stocks
a month ago
MRNA
a month ago
MRK
2 months ago
NRIX
3 months ago
LLY
5 months ago
VRTX
5 months ago
ABBV
5 months ago
VRTX
5 months ago
RPRX
5 months ago
LLY
6 months ago
ALMS
7 months ago
VRTX
9 months ago
NRIX
9 months ago
ALMS
9 months ago
BMY
9 months ago
MRK
9 months ago
GPCR
9 months ago
AMGN
9 months ago
ABBV
10 months ago
LLY
10 months ago
LLY
a year ago
LLY
a year ago
JNJ
a year ago
RPRX
a year ago
JNJ
Terence Flynn's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alumis IncALMS | 5 | Strong Buy | $29.00 | +297.81% | Maintains | 23 days ago |
Vertex Pharmaceuticals IncVRTX | 7 | Strong Buy | $665.00 | +27.30% | Reinstates | 23 days ago |
Merck & Co IncMRK | 22 | Strong Buy | $160.00 | +8.12% | Maintains | a month ago |
Moderna IncMRNA | 1 | Hold | $89.00 | -54.32% | Maintains | a month ago |
Amgen IncAMGN | 17 | Hold | $362.00 | -10.85% | Maintains | a month ago |
Biohaven LtdBHVN | 7 | Strong Buy | $19.00 | +44.05% | Maintains | a month ago |
Abbvie IncABBV | 22 | Strong Buy | $296.00 | +11.65% | Maintains | 2 months ago |
Nurix Therapeutics IncNRIX | 8 | Strong Buy | $38.00 | +60.68% | Maintains | 2 months ago |
Johnson & JohnsonJNJ | 31 | Strong Buy | $294.00 | +8.62% | Maintains | 2 months ago |
Eli Lilly & CoLLY | 24 | Strong Buy | $1,347.00 | +13.97% | Maintains | 3 months ago |
Biontech SeBNTX | 8 | Strong Buy | $119.00 | +19.89% | Maintains | 3 months ago |
Arcus Biosciences IncRCUS | 10 | Hold | $22.00 | -12.21% | Maintains | 4 months ago |
Intellia Therapeutics IncNTLA | 6 | Hold | $15.00 | +23.36% | Maintains | 5 months ago |
United Therapeutics CorpUTHR | 12 | Hold | $519.00 | +9.91% | Maintains | 5 months ago |
Royalty Pharma PLCRPRX | 14 | Strong Buy | $63.00 | +8.08% | Maintains | 5 months ago |
Pfizer IncPFE | 22 | Hold | $28.00 | -1.44% | Maintains | 5 months ago |
Bristol Myers Squibb CoBMY | 11 | Strong Sell | $37.00 | -39.84% | Maintains | 9 months ago |
Structure Therapeutics IncGPCR | 2 | Strong Buy | $125.00 | +247.03% | Maintains | 9 months ago |
Organon & CoOGN | 11 | Hold | $9.00 | -34.40% | Maintains | 10 months ago |
Arvinas IncARVN | 8 | Hold | $11.00 | N/A | Maintains | a year ago |
Crispr Therapeutics AgCRSP | 7 | Strong Sell | $32.00 | N/A | Maintains | 2 years ago |
Blueprint Medicines CorpBPMC | 5 | Strong Buy | $168.00 | N/A | Maintains | 2 years ago |
C4 Therapeutics IncCCCC | 5 | Hold | $8.00 | N/A | Maintains | 3 years ago |
Revance Therapeutics IncRVNC | 7 | Hold | $12.00 | N/A | Maintains | 3 years ago |
Neuehealth IncNEUE | 1 | Strong Buy | $2,880.00 | N/A | Initiates Coverage On | 5 years ago |
Biogen IncBIIB | 2 | Hold | $436.00 | N/A | Maintains | 5 years ago |
Translate Bio IncTBIO1 | 1 | Strong Buy | $342.00 | N/A | Initiates Coverage On | 6 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | $40.00 | N/A | Upgrades | 8 years ago |
Alnylam Pharmaceuticals IncALNY | 1 | Strong Buy | N/A | N/A | Upgrades | 9 years ago |
Kyntra Bio IncKYNB | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Bioverativ IncBIVV | 1 | Hold | N/A | N/A | Downgrades | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.